Sia Daneshmand, MD, University of Southern California, Los Angeles, CA, gives an overview of hematuria and some of the new urinary molecular marker tests in bladder cancer.
Keywords: hematuria, molecular marker tests, bladder cancer
ABOUT THE AUTHOR
Dr. Siamak Daneshmand earned his medical degree at the University of California, Davis, and completed his residency at the University of Southern California, followed by a two-year Fellowship in Urologic Oncology at the University of Southern California’s Norris Comprehensive Cancer Center. He is currently the Associate Professor of Urology and serves as Director of Clinical Research at the University of Southern California, Keck School of Medicine, and has extensive experience in the management of advanced kidney cancers and prostate cancer.
